Mystic Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Mystic Asset Management's PFE Position: Q2 2026 in Review
Mystic Asset Management reduced its Pfizer (PFE) stake by 0.9% in Q2 2026, selling an estimated $42.4K and leaving 178,085 shares worth $4.29M. The position accounts for 0.92% of the portfolio, ranked #30.
Mystic Asset Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.59M in Q3 2025. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Mystic Asset Management held 178,085 shares of Pfizer worth $4.29M as of Q2 2026.
- Mystic Asset Management sold 1,619 Pfizer shares in Q2 2026, an estimated $42.4K.
- Pfizer made up 0.92% of Mystic Asset Management's portfolio in Q2 2026, its #30 holding.
- Mystic Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Mystic Asset Management's Pfizer position peaked at $5.59M in Q3 2025.
- 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Mystic Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.